A new surface plasmon resonance-based immunoassay for rapid and sensitive quantification of D-dimer in human plasma for thrombus screening

J Chromatogr B Analyt Technol Biomed Life Sci. 2024 May 1:1238:124102. doi: 10.1016/j.jchromb.2024.124102. Epub 2024 Apr 2.

Abstract

D-dimer is a protein fragment generated during the fibrin breakdown by plasmin, and it serves as a mature biomarker for diagnosing thrombotic disorders. A novel immunoassay method based on surface plasmon resonance (SPR) has been developed, validated, and successfully applied for the quantification of D-dimer in human plasma with high sensitivity and rapidity. In this methodological study, we investigated the activity and stability of the SPR biosensor, sample pre-processing, washing conditions, intra-day and inter-day precision and accuracy and detection parameters, including a limit of detection of 8.3 ng/mL, a detection range spanning from 31.25 to 4000 ng/mL, and a detection time of 20 min. We compared D-dimer plasma concentration determination results using SPR with a classical latex-enhanced immunoturbidimetric immunoassay in 29 healthy individuals and thrombotic patients, and both methods exhibited consistency. Furthermore, we propose a hypothesis about the relationship between the concentration of D-dimer and its molecular weight. With an increase in the D-dimer concentration in plasma, the D-dimer approaches its simplest form (190 kDa).

Keywords: D-dimer; Latex-enhanced immunoturbidimetric immunoassay; Plasma; Quantification; surface plasmon resonance (SPR).

MeSH terms

  • Female
  • Fibrin Fibrinogen Degradation Products* / analysis
  • Humans
  • Immunoassay / methods
  • Limit of Detection*
  • Linear Models
  • Male
  • Reproducibility of Results
  • Surface Plasmon Resonance* / methods
  • Thrombosis* / blood

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D